Case number 1:17-cv-00867
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 26, 2018 | 13 | Patent/Trademark Report to Commissioner (1) |
| Feb 26, 2018 | 11 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal by Novartis AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) |
| Feb 26, 2018 | 12 | Order (3) Docket Text: SO ORDERED Granting (12 in 17-cv-393-RGA, 11 in 17-cv-867-RGA) Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 2/26/2018. Associated Cases: 1:17-cv-00393-RGA, 1:17-cv-00867-RGA(nms) |
| Feb 26, 2018 | 13 | Order (3) |
| Feb 26, 2018 | 13 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772. (Attachments: # (1) Order)(nms) |
| Feb 16, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION to Extend Time to respond to the Complaint to March 2, 2018, filed by Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 2/16/2018. (ksr, ) Modified on 2/20/2018 (nms). |
| Feb 16, 2018 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to respond to the Complaint to March 2, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 2/20/2018 (nms). |
| Jan 18, 2018 | N/A | SO ORDERED (0) |
| Jan 17, 2018 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to February 16, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Nov 16, 2017 | N/A | SO ORDERED (0) |
| Nov 15, 2017 | 8 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to Complaint to January 19, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Sep 20, 2017 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation, Novartis AG: For Teva Pharmaceuticals USA, Inc. waiver sent on 9/19/2017, answer due 11/20/2017. (Silver, Daniel) |
| Jul 5, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jun 30, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA, Inc. on 6/30/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs) |
| Jun 30, 2017 | 1 | Complaint (8) |
| Jun 30, 2017 | 1 | Exhibit A (16) |
| Jun 30, 2017 | 1 | Civil Cover Sheet (2) |
| Jun 30, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) |
| Jun 30, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 17, 2017. Date of Expiration of Patent: September 9, 2019.Thirty Month Stay Deadline: 11/18/2019. (jcs) Modified on 7/5/2017 (jcs). |
| Jun 30, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772. (jcs) |
| Jun 30, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Novartis AG. (jcs) |
| Jun 30, 2017 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (jcs) |
| Jun 30, 2017 | 1 | Main Document (8) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2174906.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(jcs) |
| Jun 30, 2017 | 1 | Complaint* (1) |
